Ibrahim M. El‐Deeb

1.0k total citations
38 papers, 712 citations indexed

About

Ibrahim M. El‐Deeb is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Ibrahim M. El‐Deeb has authored 38 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Organic Chemistry and 9 papers in Epidemiology. Recurrent topics in Ibrahim M. El‐Deeb's work include Respiratory viral infections research (8 papers), Synthesis and biological activity (7 papers) and Virology and Viral Diseases (5 papers). Ibrahim M. El‐Deeb is often cited by papers focused on Respiratory viral infections research (8 papers), Synthesis and biological activity (7 papers) and Virology and Viral Diseases (5 papers). Ibrahim M. El‐Deeb collaborates with scholars based in Australia, South Korea and United States. Ibrahim M. El‐Deeb's co-authors include So Ha Lee, Mark von Itzstein, Kyung Ho Yoo, Patrice Guillon, Larissa Dirr, Alaa A.‐M. Abdel‐Aziz, Magda A. El‐Sherbeny, Benjamin Bailly, Mark J. Walker and Dong Keun Han and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Ibrahim M. El‐Deeb

38 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ibrahim M. El‐Deeb Australia 17 258 242 124 101 91 38 712
Xinyong Liu China 15 284 1.1× 210 0.9× 95 0.8× 74 0.7× 101 1.1× 33 784
Mohammad Yousuf Ansari India 19 324 1.3× 255 1.1× 219 1.8× 298 3.0× 130 1.4× 63 964
Sunil Kumar Tripathi India 18 384 1.5× 138 0.6× 42 0.3× 49 0.5× 98 1.1× 54 1.1k
Huy Ngo United States 17 253 1.0× 289 1.2× 106 0.9× 24 0.2× 187 2.1× 43 812
Leentje Persoons Belgium 15 280 1.1× 323 1.3× 76 0.6× 39 0.4× 178 2.0× 66 793
Sulaiman Shams Pakistan 16 194 0.8× 109 0.5× 153 1.2× 37 0.4× 39 0.4× 58 813
Philipp Uhl Germany 17 424 1.6× 71 0.3× 70 0.6× 27 0.3× 85 0.9× 58 876
Richard A. Stanton United States 12 343 1.3× 212 0.9× 109 0.9× 56 0.6× 105 1.2× 27 803
Sufi Morshed Japan 17 197 0.8× 99 0.4× 50 0.4× 78 0.8× 59 0.6× 22 697
Ritu Shrestha United States 21 549 2.1× 174 0.7× 129 1.0× 26 0.3× 354 3.9× 36 1.3k

Countries citing papers authored by Ibrahim M. El‐Deeb

Since Specialization
Citations

This map shows the geographic impact of Ibrahim M. El‐Deeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim M. El‐Deeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim M. El‐Deeb more than expected).

Fields of papers citing papers by Ibrahim M. El‐Deeb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim M. El‐Deeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim M. El‐Deeb. The network helps show where Ibrahim M. El‐Deeb may publish in the future.

Co-authorship network of co-authors of Ibrahim M. El‐Deeb

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim M. El‐Deeb. A scholar is included among the top collaborators of Ibrahim M. El‐Deeb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim M. El‐Deeb. Ibrahim M. El‐Deeb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jen, Freda E.‐C., Jennifer L. Edwards, Ibrahim M. El‐Deeb, et al.. (2022). Repurposing the Ionophore, PBT2, for Treatment of Multidrug-Resistant Neisseria gonorrhoeae Infections. Antimicrobial Agents and Chemotherapy. 66(9). e0231821–e0231821. 3 indexed citations
2.
Dirr, Larissa, et al.. (2019). Targeting Human Parainfluenza Virus Type-1 Haemagglutinin-Neuraminidase with Mechanism-Based Inhibitors. Viruses. 11(5). 417–417. 4 indexed citations
3.
Dirr, Larissa, Patrice Guillon, Ibrahim M. El‐Deeb, et al.. (2019). New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase. Antiviral Research. 167. 89–97. 25 indexed citations
4.
Oliveira, David M. P. De, Ibrahim M. El‐Deeb, Erin B. Brazel, et al.. (2018). Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance. mBio. 9(6). 58 indexed citations
5.
Greish, Khaled, Valeria Pittalà, Sébastien Taurin, et al.. (2018). Curcumin–Copper Complex Nanoparticles for the Management of Triple-Negative Breast Cancer. Nanomaterials. 8(11). 884–884. 39 indexed citations
6.
7.
Dirr, Larissa, Ibrahim M. El‐Deeb, Leonard M. G. Chavas, Patrice Guillon, & Mark von Itzstein. (2017). The impact of the butterfly effect on human parainfluenza virus haemagglutinin-neuraminidase inhibitor design. Scientific Reports. 7(1). 4507–4507. 12 indexed citations
8.
Bailly, Benjamin, Larissa Dirr, Ibrahim M. El‐Deeb, et al.. (2016). A dual drug regimen synergistically blocks human parainfluenza virus infection. Scientific Reports. 6(1). 24138–24138. 18 indexed citations
9.
Dirr, Larissa, et al.. (2015). The Catalytic Mechanism of Human Parainfluenza Virus Type 3 Haemagglutinin‐Neuraminidase Revealed. Angewandte Chemie International Edition. 54(10). 2936–2940. 26 indexed citations
10.
Guillon, Patrice, Larissa Dirr, Ibrahim M. El‐Deeb, et al.. (2014). Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin–neuraminidase inhibitors. Nature Communications. 5(1). 5268–5268. 32 indexed citations
11.
Hong, Sang‐Won, Kyung Hee Jung, Myung‐Joo Choi, et al.. (2012). Anticancer effects of KI-10F: A novel compound affecting apoptosis, angiogenesis and cell growth in colon cancer. International Journal of Oncology. 41(5). 1715–1722. 4 indexed citations
12.
Ibrahim, Diaa A., et al.. (2011). A novel potential therapeutic avenue for autism: Design, synthesis and pharmacophore generation of SSRIs with dual action. Bioorganic & Medicinal Chemistry Letters. 21(22). 6714–6723. 7 indexed citations
13.
El‐Deeb, Ibrahim M., et al.. (2011). A Highly Selective Staurosporine Derivative Designed by a New Selectivity Filter. Bulletin of the Korean Chemical Society. 32(5). 1709–1714. 2 indexed citations
14.
El‐Deeb, Ibrahim M., Kyung Ho Yoo, & So Ha Lee. (2010). ROS receptor tyrosine kinase: a new potential target for anticancer drugs. Medicinal Research Reviews. 31(5). n/a–n/a. 54 indexed citations
15.
El‐Deeb, Ibrahim M. & So Ha Lee. (2010). Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity. Bioorganic & Medicinal Chemistry. 18(11). 3961–3973. 31 indexed citations
16.
El‐Deeb, Ibrahim M. & So Ha Lee. (2010). Design and synthesis of new anticancer pyrimidines with multiple-kinase inhibitory effect. Bioorganic & Medicinal Chemistry. 18(11). 3860–3874. 32 indexed citations
17.
El‐Deeb, Ibrahim M., et al.. (2010). Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction. European Journal of Medicinal Chemistry. 45(6). 2516–2530. 55 indexed citations
18.
El‐Deeb, Ibrahim M., et al.. (2010). New Phenylaminopyrimidine (PAP) Anticancer Lead Compound with High Efficacy: Design, Synthesis, and in vitro Screening. Bulletin of the Korean Chemical Society. 31(7). 1848–1858. 2 indexed citations
19.
El‐Deeb, Ibrahim M., Su‐Jin Jung, Kyung Ho Yoo, et al.. (2009). Design, synthesis, screening, and molecular modeling study of a new series of ROS1 receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(19). 5622–5626. 31 indexed citations
20.
El‐Deeb, Ibrahim M., Kyung Ho Yoo, Chang‐Hyun Oh, et al.. (2009). Design, synthesis and biological evaluation of new potent and highly selective ROS1-tyrosine kinase inhibitor. Bioorganic & Medicinal Chemistry Letters. 19(16). 4720–4723. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinyong Liu Breakdown of academic impact, for papers by Mohammad Yousuf Ansari Breakdown of academic impact, for papers by Sunil Kumar Tripathi Breakdown of academic impact, for papers by Huy Ngo Breakdown of academic impact, for papers by Leentje Persoons Breakdown of academic impact, for papers by Sulaiman Shams Breakdown of academic impact, for papers by Philipp Uhl Breakdown of academic impact, for papers by Richard A. Stanton Breakdown of academic impact, for papers by Sufi Morshed Breakdown of academic impact, for papers by Ritu Shrestha
Rankless by CCL
2026